Jim Simons Xeris Biopharma Holdings, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,622,840 shares of XERS stock, worth $11.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,622,840

Previous 2,055,340 21.04%

Holding current value

$11.8 Million

Previous $9.6 Million 36.96%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.68 - $8.3 $2.02 Million - $3.59 Million	-432,500 Reduced 21.04%	1,622,840 $13.1 Million
Q2 2025 Aug 13, 2025	SELL	$3.95 - $5.16 $423,835 - $553,668	-107,300 Reduced 4.96%	2,055,340 $9.6 Million
Q1 2025 May 14, 2025	BUY	$3.2 - $5.95 $204,160 - $379,610	63,800 Added 3.04%	2,162,640 $11.9 Million
Q4 2024 Feb 13, 2025	BUY	$2.78 - $3.73 $1.39 Million - $1.87 Million	500,120 Added 31.28%	2,098,840 $7.12 Million
Q3 2024 Nov 13, 2024	BUY	$2.06 - $2.96 $508,984 - $731,356	247,080 Added 18.28%	1,598,720 $4.56 Million

Q2 2024 Aug 09, 2024	BUY	$1.7 - $2.45 $581,910 - $838,635	342,300 Added 33.91%	1,351,640 $3.04 Million
Q1 2024 May 13, 2024	SELL	$2.04 - $3.22 $759,492 - $1.2 Million	-372,300 Reduced 26.95%	1,009,340 $2.23 Million
Q4 2023 Feb 13, 2024	BUY	$1.47 - $2.36 $528,612 - $848,656	359,600 Added 35.18%	1,381,640 $3.25 Million
Q3 2023 Nov 14, 2023	BUY	$1.8 - $2.69 $294,022 - $439,400	163,346 Added 19.02%	1,022,040 $1.9 Million
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $463,736 - $759,304	254,800 Added 42.19%	858,694 $2.25 Million
Q1 2023 May 12, 2023	BUY	$1.03 - $1.63 $108,562 - $171,802	105,400 Added 21.14%	603,894 $984,000
Q4 2022 Feb 13, 2023	SELL	$1.14 - $1.65 $58,367 - $84,480	-51,200 Reduced 9.31%	498,494 $663,000
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $128,780 - $181,420	-94,000 Reduced 14.6%	549,694 $858,000
Q2 2022 Aug 12, 2022	SELL	$1.48 - $2.64 $72,964 - $130,152	-49,300 Reduced 7.11%	643,694 $991,000
Q1 2022 May 13, 2022	SELL	$2.0 - $2.87 $374,400 - $537,264	-187,200 Reduced 21.27%	692,994 $1.77 Million
Q4 2021 Feb 11, 2022	BUY	$1.8 - $2.93 $1.58 Million - $2.58 Million	880,194 New	880,194 $2.58 Million

Others Institutions Holding XERS

# of Institutions

236

Shares Held

94.1M

Call Options Held

251K

Put Options Held

61.8K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $986M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account